{"disease":{"id":"hematological-malignancies","name":"hematological malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04142372","title":"Tissue Microarray of Hematological Malignancies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT04733729","title":"Covid-19 in Hematological Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne","has_results":false},{"nct_id":"NCT06607289","title":"National Longitudinal Cohort of Hematological Diseases (NICHE) - CART","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06550102","title":"Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT06674330","title":"Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT04634552","title":"A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05103995","title":"Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07220616","title":"A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT05290545","title":"Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03145181","title":"Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":302,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04878822","title":"Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ospedale di Circolo - Fondazione Macchi","has_results":false},{"nct_id":"NCT06150469","title":"Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies","phase":"NA","overall_status":"RECRUITING","enrollment_count":286,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT01607892","title":"Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Karyopharm Therapeutics Inc","has_results":true},{"nct_id":"NCT03399799","title":"Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":279,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03248479","title":"Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":258,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04352556","title":"COVID19-hematological Malignancies: the Italian Hematology Alliance","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Ospedale di Circolo - Fondazione Macchi","has_results":false},{"nct_id":"NCT03733340","title":"Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04557098","title":"A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":194,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05005442","title":"A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05728658","title":"The Study of ICP-248 in Patients With Mature B-cell Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":191,"lead_sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","has_results":false},{"nct_id":"NCT04657965","title":"LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":144,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT06387082","title":"A Clinical Study of HMPL-506 in Patients With Hematological Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Hutchmed","has_results":false},{"nct_id":"NCT02730299","title":"Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Gamida Cell ltd","has_results":true},{"nct_id":"NCT06834412","title":"A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05306509","title":"Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT02223598","title":"A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":120,"lead_sponsor_name":"Cleave Biosciences, Inc.","has_results":false},{"nct_id":"NCT05020639","title":"A Study of TQB3820 in Patients With Hematological Malignancies","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":116,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06224855","title":"A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Hangzhou DAC Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT02576496","title":"Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Mundipharma Research Limited","has_results":false},{"nct_id":"NCT04283006","title":"A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"He Huang","has_results":false},{"nct_id":"NCT01916057","title":"Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06041815","title":"Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07047352","title":"Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":91,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06904066","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00824993","title":"Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT01349101","title":"A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":true},{"nct_id":"NCT07137481","title":"Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT00179764","title":"Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT02194868","title":"Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)","phase":"","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06179511","title":"Study of AZD9829 in CD123+ Hematological Malignancies","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07532746","title":"A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":55,"lead_sponsor_name":"Kousai Bio Co., Ltd.","has_results":false},{"nct_id":"NCT03837899","title":"Durvalumab and Tremelimumab for Pediatric Malignancies","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07472972","title":"Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT04944771","title":"Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01315132","title":"A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":true},{"nct_id":"NCT07362602","title":"Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":47,"lead_sponsor_name":"The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army","has_results":false},{"nct_id":"NCT06258629","title":"Prognostic Value of \"CD200\" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT02215070","title":"Pasireotide in Prevention of GI Toxicity","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Anthony Sung, MD","has_results":true},{"nct_id":"NCT04662788","title":"Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT04260698","title":"Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Gamida Cell ltd","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}